Encompass Health Declares $0.19 Quarterly Cash Dividend Payable April 15, 2026

Encompass Health declares quarterly cash dividend as part of capital allocation

Encompass Health Corp. announces a quarterly cash dividend of $0.19 per share on common stock, payable April 15, 2026 to holders of record as of April 1, 2026. The Birmingham, Alabama-based company communicates the board’s action in a Feb. 19 release, framing the dividend as a routine component of its capital allocation policy.

The dividend declaration underlines the company’s continuing emphasis on returning cash to shareholders while it maintains its operational focus on inpatient rehabilitation services. Encompass Health, which operates a national footprint of 173 hospitals across 39 states and Puerto Rico, is positioned as the largest owner and operator of inpatient rehabilitation hospitals in the United States and continues to provide rehabilitative care using advanced technology and innovative treatments.

Management flags the declaration as a forward-looking decision subject to customary risks and board discretion, noting that future dividend timing and amounts could change. The company reminds stakeholders that such statements are estimates based on current information and may be affected by regulatory, economic or other developments.

National footprint and care model

Encompass Health continues to stress its scale and service model in tandem with the dividend announcement, highlighting its role in post-acute care delivery across a broad geographic footprint. The company emphasizes use of advanced therapeutic technologies and innovative treatments as central to its inpatient rehabilitation offerings, which serve patients recovering from stroke, brain and spinal cord injuries, joint replacements and other complex conditions.

Recognition and regulatory caution

The company remains publicly recognized for its sector performance, being named “America’s Most Awarded Leader in Inpatient Rehabilitation” by Newsweek and Statista and appearing on lists compiled by Fortune and Forbes. Alongside these recognitions, Encompass Health reiterates the regulatory and economic caveats tied to its forward-looking statements, citing potential impacts from government actions, legal and administrative developments, and broader economic or geopolitical instability that could alter its financial plans.